Delivery Order SPE2DB22D1106-SPE2DB25FFJG7
- Not listed
- The Defense Logistics Agency awarded a $9,009.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.10 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was processed through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,986.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a $3,169.95 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a ceiling value of $8,630.84. This firm fixed-price delivery order, which is set to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The medication will be fulfilled from...
- The Defense Logistics Agency awarded a $8,972.39 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. This competitive award, utilizing firm fixed-price terms with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJG7Delivery Order
The Defense Logistics Agency awarded a $9,170.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen injectors on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and supplies Trulicity, a diabetes management medication, to support military and federal healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the DLA's Medical Supply Chain, fulfilling routine medical procurement needs for the Defense Health Agency and other government healthcare systems. The pharmaceutical distributor maintains an extensive portfolio of federal contracts spanning brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As the prime contractor on this delivery order and the larger SPE2DX indefinite delivery vehicle, AmerisourceBergen continues to demonstrate its capability to meet federal procurement requirements for military healthcare support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 9/16/25 |